XML 34 R2.htm IDEA: XBRL DOCUMENT v2.4.0.8
CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (USD $)
Dec. 31, 2013
Mar. 31, 2013
Current assets    
Cash $ 1,854,941 $ 125,274
Accounts receivable 45,009 208,781
Deferred financing costs 0 863
Prepaid expenses and other current assets 18,700 29,602
Total current assets 1,918,650 364,520
Property and equipment, net 54,352 145
Patents and patents pending, net 114,780 121,653
Deposits 17,226 10,376
Total assets 2,105,008 496,694
Current Liabilities    
Accounts payable 790,272 822,832
Due to related parties 784,570 736,070
Notes payable 390,000 321,381
Convertible notes payable, net of discounts 2,244,942 2,367,631
Derivative liabilities 5,576,065 3,588,239
Accrued liquidated damages 437,800 437,800
Other current liabilities 2,426,263 1,367,185
Total current liabilities 12,649,912 9,641,138
Commitments and Contingencies (Note 12)      
Stockholders' Deficit    
Common stock, par value $0.001 per share; 500,000,000 shares authorized as of December 31, 2013 and March 31, 2013; 209,168,197 and 173,674,201 shares issued and outstanding as of December 31, 2013 and March 31, 2013, respectively 209,170 173,685
AdditionalPaid-In Capital 56,193,786 52,157,196
Accumulated deficit (67,210,799) (61,475,325)
Total Aethlon Medical, Inc. stockholders' deficit (10,807,843) (9,144,444)
Noncontrolling interests 262,939 0
Total stockholders' deficit (10,544,904) (9,144,444)
Total liabilities and stockholders' deficit $ 2,105,008 $ 496,694